PBP — Probiotec Balance Sheet
0.000.00%
HealthcareBalancedSmall Cap
- AU$242.34m
- AU$315.62m
- AU$214.03m
Annual balance sheet for Probiotec, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | C2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | Interim Report | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 8.84 | 6.31 | 28.4 | 22.2 | 14.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 18.8 | 22.9 | 24.5 | 31.2 | 36.4 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 47.1 | 46.2 | 67.8 | 74.6 | 75.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 34.2 | 36.6 | 64.1 | 62.2 | 61 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 106 | 134 | 231 | 238 | 235 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 19.2 | 25.7 | 44.4 | 52.4 | 93.7 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 56.5 | 73.5 | 162 | 159 | 148 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 49.8 | 60.5 | 68.6 | 79 | 87.1 |
| Total Liabilities & Shareholders' Equity | 106 | 134 | 231 | 238 | 235 |
| Total Common Shares Outstanding |